| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
|
Shoji, Tadahiro
|
|
2017
|
80 |
2 |
p. 355-361
|
article
|
| 2 |
A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo
|
Ueno, Makoto
|
|
2017
|
80 |
2 |
p. 307-315
|
article
|
| 3 |
Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes
|
Miles, Dale R.
|
|
2017
|
80 |
2 |
p. 295-306
|
article
|
| 4 |
Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague–Dawley rats
|
Forsgård, Richard A.
|
|
2017
|
80 |
2 |
p. 317-332
|
article
|
| 5 |
Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells
|
Xu, Li
|
|
2017
|
80 |
2 |
p. 235-242
|
article
|
| 6 |
Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience
|
Mendivil, Alberto A.
|
|
2017
|
80 |
2 |
p. 405-410
|
article
|
| 7 |
Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity
|
Liu, Chengcheng
|
|
2017
|
80 |
2 |
p. 287-293
|
article
|
| 8 |
Does “OPTINAB” strategy (“stop-and-go”) work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel–gemcitabine?
|
Relias, Valerie
|
|
2017
|
80 |
2 |
p. 371-375
|
article
|
| 9 |
Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring
|
Sabanathan, Dhanusha
|
|
2017
|
80 |
2 |
p. 385-393
|
article
|
| 10 |
Eribulin shows high concentration and long retention in xenograft tumor tissues
|
Sugawara, Michiko
|
|
2017
|
80 |
2 |
p. 377-384
|
article
|
| 11 |
Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer
|
Tsyganov, Matvey M.
|
|
2017
|
80 |
2 |
p. 251-260
|
article
|
| 12 |
Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation
|
Ouyang, Wen-Chen
|
|
2017
|
80 |
2 |
p. 411-419
|
article
|
| 13 |
Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients
|
Park, Wan-Su
|
|
2017
|
80 |
2 |
p. 363-369
|
article
|
| 14 |
Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients
|
Burhenne, Jürgen
|
|
2017
|
80 |
2 |
p. 433-439
|
article
|
| 15 |
Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity
|
Quintanilha, Júlia Coelho França
|
|
2017
|
80 |
2 |
p. 223-233
|
article
|
| 16 |
JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin
|
Qiu, Mingning
|
|
2017
|
80 |
2 |
p. 275-286
|
article
|
| 17 |
Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma
|
Ren, Kaiming
|
|
2017
|
80 |
2 |
p. 243-250
|
article
|
| 18 |
Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring
|
Netterberg, Ida
|
|
2017
|
80 |
2 |
p. 343-353
|
article
|
| 19 |
Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy
|
Boss, M. K.
|
|
2017
|
80 |
2 |
p. 421-431
|
article
|
| 20 |
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer
|
Takayoshi, Kotoe
|
|
2017
|
80 |
2 |
p. 333-342
|
article
|
| 21 |
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
|
Burris, Howard A.
|
|
2017
|
80 |
2 |
p. 261-273
|
article
|
| 22 |
Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1)
|
Yan, Xiaofei
|
|
2017
|
80 |
2 |
p. 395-403
|
article
|
Journal description